Viemed Healthcare, Inc.
VMDNasdaqCIK 1729149HealthcareFiscal year ends Dec 31
Reports and events: 132 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-09-2417:22 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001781905-26-000019 |
| 2026-08-2017:03 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001729149-26-000048 |
| 2026-08-0317:04 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001729149-26-000042 |
| 2026-08-0317:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001729149-26-000041 |
| 2026-06-0416:07 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001729149-26-000034 |
| 2026-06-0217:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001729149-26-000032 |
| 2026-05-0517:02 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001729149-26-000029 |
| 2026-05-0517:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001729149-26-000028 |
| 2026-04-2216:45 ET | DEF 14A | Proxy statementPeriod 2026-04-22 | 0001729149-26-000022 |
| 2026-03-1616:51 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001729149-26-000011 |
| 2026-03-0416:50 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001729149-26-000009 |
| 2026-03-0416:47 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001729149-26-000008 |
| 2025-11-0716:02 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure | 0001729149-25-000151 |
| 2025-11-0516:40 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001729149-25-000149 |
| 2025-11-0516:38 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001729149-25-000148 |
| 2025-09-2317:01 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001729149-25-000142 |
| 2025-08-0617:06 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001729149-25-000119 |
| 2025-08-0617:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001729149-25-000118 |
| 2025-07-0208:46 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001729149-25-000112 |
| 2025-06-0908:12 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001729149-25-000101 |
| 2025-06-0517:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001729149-25-000098 |
| 2025-05-0716:50 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001729149-25-000096 |
| 2025-05-0716:47 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001729149-25-000095 |
| 2025-05-0608:34 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001729149-25-000086 |
| 2025-04-2508:45 ET | DEF 14A | Proxy statementPeriod 2025-04-25 | 0001729149-25-000079 |
| 2025-04-1416:29 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001729149-25-000067 |
| 2025-03-1816:26 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001729149-25-000062 |
| 2025-03-1017:08 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001729149-25-000056 |
| 2025-03-1017:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001729149-25-000055 |
| 2024-11-1208:04 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001729149-24-000213 |
| 2024-11-0616:48 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001729149-24-000210 |
| 2024-11-0616:47 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001729149-24-000209 |
| 2024-08-1416:53 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001729149-24-000170 |
| 2024-08-0717:06 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001729149-24-000162 |
| 2024-08-0717:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001729149-24-000160 |
| 2024-06-0617:24 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001729149-24-000152 |
| 2024-05-2917:11 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001729149-24-000148 |
| 2024-05-0917:24 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001729149-24-000123 |
| 2024-05-0617:04 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001729149-24-000102 |
| 2024-05-0617:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001729149-24-000101 |
| 2024-04-2609:08 ET | DEF 14A | Proxy statementPeriod 2024-04-26 | 0001729149-24-000096 |
| 2024-04-0209:07 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001729149-24-000088 |
| 2024-03-1116:47 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001729149-24-000079 |
| 2024-03-0617:09 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001729149-24-000077 |
| 2024-03-0617:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001729149-24-000075 |
| 2024-02-1509:27 ET | SC 13D/A | Ownership report, active investor, amended | 0001781905-24-000002 |
| 2023-12-0709:02 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events | 0001729149-23-000170 |
| 2023-11-0817:38 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001729149-23-000164 |
| 2023-11-0117:03 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001729149-23-000161 |
| 2023-11-0117:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001729149-23-000160 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:07 ET. Listed shows no prices and gives no investment advice.